Latest News

UBS said demand for Freshworks products continued to be a “tale of two cities.”
Via Stocktwits · February 6, 2025

Citi lowered its price target on Uber to $92 from $98 while keeping a ‘Buy’ rating on the shares. JPMorgan lowered its price target on the stock to $90 from $95 while keeping an ‘Overweight’ rating on the shares.
Via Stocktwits · February 6, 2025
The latest projections for Gold & Silver based on our analogs. Note that gold must outperform the stock market for these various targets to be reached.
Via Talk Markets · February 6, 2025

Balancing Dividends and Fundamentals: The Case of SONOCO PRODUCTS CO (NYSESON).
Via Chartmill · February 6, 2025

Older diabetes medicines outperformed expectations, helping offset the shortfall in Lilly’s newer treatments.
Via Stocktwits · February 6, 2025

Government debt has nearly doubled since 2018, topping $36 trillion. Soon, interest expense will eat up the entire federal budget.
Via Talk Markets · February 6, 2025

Analyzing KT CORP-SP ADR (NYSEKT)'s Dividend Potential.
Via Chartmill · February 6, 2025

Qualcomm had previously benefited from its agreement with Huawei, but the current outlook excludes potential Huawei licensing revenue, though discussions are ongoing, according to management.
Via Stocktwits · February 6, 2025

Athletic apparel company Under Armour (NYSEUAA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 5.7% year on year to $1.40 billion. Its non-GAAP profit of $0.08 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 6, 2025

Empowering Women of Color and Elevating Beauty Rituals in Figure Skating
Via News Direct · February 6, 2025

The company won three FDA approvals over the past two years. Now, it's angling for two new approvals in 2025.
Via Investor's Business Daily · February 6, 2025

Hilton Worldwide delivered better-than-expected earnings as it navigates a challenging backdrop for the hospitality industry.
Via The Motley Fool · February 6, 2025

Is QUALCOMM INC (NASDAQQCOM) a Good Fit for Dividend Investing?
Via Chartmill · February 6, 2025

Via The Motley Fool · February 6, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSEBMY) announced better-than-expected revenue in Q4 CY2024, with sales up 7.5% year on year to $12.34 billion. On the other hand, the company’s full-year revenue guidance of $45.5 billion at the midpoint came in 1.7% below analysts’ estimates. Its non-GAAP profit of $1.67 per share was 13.8% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

Walmart is hovering around its 52-week high, up nearly 14% this year, however, over-optimistic momentum indicators hint at a likely pullback.
Via Benzinga · February 6, 2025

Tobacco company Philip Morris International (NYSEPM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.3% year on year to $9.71 billion. Its non-GAAP profit of $1.55 per share was 3.4% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

The company’s quarterly revenue fell 26.6% to $1.16 billion compared to last year. Analysts, on average, expected the company to post $1.25 billion in revenue.
Via Stocktwits · February 6, 2025

The Dow software giant named Robin Washington, as its new CFO and COO.
Via Investor's Business Daily · February 6, 2025

EUR/USD is falling after two days of gains, dropping below 104 as a broad rebound in the US dollar weighs on the pair.
Via Talk Markets · February 6, 2025

A fundamental analysis of (NASDAQCOKE): Why the quality investor may take a look at COCA-COLA CONSOLIDATED INC NASDAQ:COKENASDAQCOKE)
Via Chartmill · February 6, 2025

Exercise equipment company Peloton (NASDAQPTON) announced better-than-expected revenue in Q4 CY2024, but sales fell by 9.4% year on year to $673.9 million. On the other hand, next quarter’s revenue guidance of $615 million was less impressive, coming in 6% below analysts’ estimates. Its GAAP loss of $0.24 per share was 25.9% below analysts’ consensus estimates.
Via StockStory · February 6, 2025

The stock market recovery has been a bit lopsided, but that could change soon.
Via The Motley Fool · February 6, 2025

The real (inflation-adjusted) goods deficit increased $14.9 billion, or 15.4 percent, to $111.9 billion in December, compared to a 17.3 percent increase in the nominal deficit.
Via Talk Markets · February 6, 2025

TALEN ENERGY CORP is a hidden gem, featuring undervaluation and robust fundamentals. NASDAQ:TLN showcases decent financial health and profitability, coupled with an attractive price.
Via Chartmill · February 6, 2025

Thursday marked the final day for federal employees to accept the Trump administration's offer of eight months of pay and benefits in exchange for voluntarily stepping down.
Via Talk Markets · February 6, 2025
Eli Lilly and Company reported a robust revenue growth of 45% in Q4 2024, reaching $13.53 billion, driven by increased volume from key products.
Via Talk Markets · February 6, 2025

Water management company Advanced Drainage Systems (NYSEWMS) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 4.3% year on year to $690.5 million. The company expects the full year’s revenue to be around $2.94 billion, close to analysts’ estimates. Its non-GAAP profit of $1.09 per share was 9.8% below analysts’ consensus estimates.
Via StockStory · February 6, 2025

The three companies—Honeywell Automation, Honeywell Aerospace, and Advanced Materials— will have distinct strategies and growth drivers.
Via Stocktwits · February 6, 2025

Freight delivery company XPO (NYSEXPO) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.92 billion. Its non-GAAP profit of $0.89 per share was 41.6% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

Ford Motor Co CEO Jim Farley addressed the uncertainty surrounding proposed tariffs on imports from Mexico and Canada on U.S. automakers, saying it would wipe out billions of dollars of industry profits if protracted.
Via Benzinga · February 6, 2025

Luxury fashion conglomerate Tapestry (NYSETPR) announced better-than-expected revenue in Q4 CY2024, with sales up 5.3% year on year to $2.20 billion. The company’s full-year revenue guidance of $6.85 billion at the midpoint came in 1.4% above analysts’ estimates. Its GAAP profit of $1.38 per share was 12.7% below analysts’ consensus estimates.
Via StockStory · February 6, 2025

The European Central Bank (ECB) is hopeful that the recent support for dollar-pegged cryptocurrencies from U.S. President Donald Trump will speed up the legislative approval process for the digital euro.
Via Benzinga · February 6, 2025
After the tariff scare on Monday, which saw the US dollar surge, it has pulled back in the last couple of days.
Via Talk Markets · February 6, 2025

Chocolate company Hershey (NYSEHSY) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 8.7% year on year to $2.89 billion. Its non-GAAP profit of $2.69 per share was 13.3% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

BoJ’s Naoki Tamura said on Thursday that the central bank should raise rates to 1%. The dollar remained fragile after a pause in some of Trump’s tariffs. Traders are looking forward to the US nonfarm payrolls report.
Via Talk Markets · February 6, 2025

Eli Lilly earnings beat Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
Via Investor's Business Daily · February 6, 2025

Fast-food company Yum! Brands (NYSEYUM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 16% year on year to $2.36 billion. Its non-GAAP profit of $1.61 per share was 0.9% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

Microsoft co-founder Bill Gates on Monday disclosed that he has donated $100 billion to charitable causes.
Via Benzinga · February 6, 2025

Via The Motley Fool · February 6, 2025

The US Dollar is starting to recover against most major peers in the G10 space.
Via Talk Markets · February 6, 2025

Global pharmaceutical company Eli Lilly (NYSELLY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. The company’s full-year revenue guidance of $59.5 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $5.32 per share was 4.7% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

NETEASE INC-ADR may be an undervalued stock option. NASDAQ:NTES retains a strong financial foundation and an attractive price tag.
Via Chartmill · February 6, 2025

While analysts are optimistic about BlackBerry’s Cylance divestment, they are skeptical about its near-term fundamentals.
Via Stocktwits · February 6, 2025

Healthcare tech company Omnicell (NASDAQOMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.
Via StockStory · February 6, 2025

Via Benzinga · February 6, 2025

Via Benzinga · February 6, 2025